New Delhi, Feb 10 (IANS) AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment for an additional indication.In its latest stock exchange filing, the drug company said that through this approval, “Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or rec…
Trending
- Onekdin Por Review (2026): A Quietly Powerful Bengali Drama That Heals the Heart
- Carry On Jatta 4 Review (2026): Punjabi Comedy’s Most Beloved Franchise Returns With Even Bigger Laughs
- Moda Kavida Vaatavarana (2026) Review: Suni Weaves a Hauntingly Beautiful Monsoon Drama That Lingers Long After the Credits
- UYiR Movie Review (2026): Roshan Mathew Delivers a Gripping Performance in This Malayalam Crime Thriller
- Tera Mera Nata Review (2026): A Heartfelt Tale of Love, Family, and Sacrifice
- Heartin Movie Review: Sananth and Madonna Sebastian Deliver a Visually Stunning Tamil Romance Worth Your Time
- Risk – A Game of Youth Review: A Gritty Crime Drama That Takes Bold Chances With Youth and Ambition
- Balaramana Dinagalu Review: Vinod Prabhakar’s Gritty Gangster Drama Is a Compelling Ride Worth Watching